Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

FDA Probes Serious Risk Of Secondary Cancer Following CAR T Cell Therapies

Por: RTTNews Health November 29, 2023

thumbnail

The Food and Drug Administration or FDA said it is investigating serious risk of T-cell malignancies following BCMA or CD19-directed autologous Chimeric Antigen Receptor or CAR T cell Immunotherapies.The overall benefits of these products continue to outweigh their potential risks for their approved uses, the agency noted.According to the American Cancer Society, CAR T-cell therapy is a way to get immune cells called T cells (a type of white... + full article



Similar News

Newly found ‘kill switch’ triggers death of cancer cells in potential breakthrough

New York Post USA Tech November 12, 2023

thumbnailResearchers say they’ve located a “kill switch” that can trigger the death of cancer cells. Scientists at the UC Davis Comprehensive Cancer Center in Sacramento, California, have identified a protein on the CD95 receptor that can “program” cancer cells to die, as... + más

T cells burn out just a few hours after encountering cancer tumors | Ars Technica

Maker of rapid-fire triggers falsely told customers they are legal, judge says | ABC News


Potential cure for sickle cell disease raises few concerns for FDA panel

CBS News USA Politics November 01, 2023

thumbnailA panel of the Food and Drug Administration's outside advisers voiced few concerns Tuesday during a daylong wrestling with any potential risks posed by a new therapy that could cure sickle cell disease using a called .If approved by the FDA, the infusion called exa-cel,... + más

Study: Too few kids with sickle cell get stroke screen, care | Associated Press

FDA considers 1st CRISPR gene editing treatment that may cure sickle cell disease | ABC7


5 takeaways from POLITICO’s Next Generation of Health Care Therapies Event

Politico USA Health July 21, 2023

thumbnailTherapies that change genes are spurring innovative treatments for intractable diseases. The Food and Drug Administration has approved eight gene therapies in the past year and a half, including one last month to treat a rare muscular disorder. More are under review. POLITICO... + más

'The Bachelor' season 27 cast revealed: Meet the ladies vying for Zach Shallcross' heart | ABC News

Super Bowl menu ideas and recipes | CBS News


Progress In Tissue Engineering: Controlling Cell-Cell Signaling

Forbes USA Tech January 17, 2023

thumbnailCellular adhesion remains a fundamental component to cell-cell communicationGETTY Cells are the fundamental unit of life. The average human body contains around 30 trillion cells with varying functions and potentials. Communication between cells is central to the body’s... + más

States Where Biomedical Engineers Earn The Most Money In 2022 | Forbes

Those Pregnancy Tissue Photos Were Destined to Backfire on Abortion Rights Supporters | Slate


Duke, MIT, and Stanford scientists create RNA technology that could improve genetic therapies

The Boston Globe USA Business November 06, 2022

thumbnailScientists from Duke, MIT, and Stanford have independently devised a molecular trick that could help make genetic therapies safer and more effective. The technology, which was disclosed in three separate papers published recently, could help ensure that treatments based on DNA... + más

Boston startup Ascidian Therapeutics charts vision for therapies that ‘rewrite RNA’ | The Boston Globe

Sally Kornbluth named next MIT president | The Boston Globe


What Are Vampire Facials And Other Vampire Therapies? A Doctor Explains

Forbes USA Life October 16, 2022

thumbnailA vampire facial isn't your typical trip to the esthetician—here's what to expect.getty Vampire facials aren’t new—they’ve been around for decades. However, thanks to celebrities and media coverage, the microneedling procedure has gained more attention—and... + más

Who wrote Interview with the Vampire? | Newsweek

'Interview with the Vampire' is a new series based on Anne Rice's bestselling horror novel — here's how to watch new episodes | Business Insider


Boston startup Ascidian Therapeutics charts vision for therapies that ‘rewrite RNA’

The Boston Globe USA Business October 12, 2022

thumbnailCompetition is heating up among biotech startups building technologies that improve or expand upon what gene editing can do. While most of these firms are devising therapies that permanently modify DNA to treat, and potentially cure, genetic diseases, a growing number think that... + más

Tech insiders have a lot to say about the local startup scene. Most of it is good. | The Boston Globe

See the presentations that hot healthcare startups used to raise millions from top VCs | Business Insider



About iurex | Privacy Policy | Disclaimer |